Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

amlodipine

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of amlodipine

60 trials tracked of amlodipine: 40 in phase 3 or 4 and 5 with published results. The most-cited published study has 129 citations.

60Trials tracked

40Phase 3 & 4

0Recruiting

5With published results

Phase distribution

Phase 4 19 Phase 3 21 Phase 2 8 Phase 1 6 Other / NA 6

Phase 4 Nephropathy In Type 2 Diabetes and Cardio-renal Events Completed · 129 cited
Phase 3 MK-0954E Study in Participants With Hypertension (MK-0954E-357) Completed · 12 cited
Phase 3 A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension Completed · 11 cited
Phase 4 N-of-1 Trials In Children With Hypertension Completed · 9 cited
Phase 4 BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF Completed
Phase 4 Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation Completed

Show 44 more trials

Phase 4 Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism Completed
Phase 4 Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy Completed
Phase 4 Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension Completed
Phase 4 Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy Completed
Phase 4 INTERVENCION Trial Completed
Phase 4 Black Education and Treatment of Hypertension (BEAT HTN) Completed
Phase 4 The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction Completed
Phase 4 Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension Completed
Phase 4 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics Completed
Phase 4 ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling Completed
Phase 4 Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day Completed
Phase 4 A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk Completed
Phase 4 Direct Renin Inhibition Effects on Atherosclerotic Biomarkers Completed
Phase 4 Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension Completed
Phase 4 Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus Completed
Phase 3 Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine Completed
Phase 3 Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age Completed
Phase 3 Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient Completed
Phase 3 A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient Completed
Phase 3 Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension Completed
Phase 3 Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension Completed
Phase 3 Perindopril Amlodipine for the Treatment of Hypertension Completed
Phase 3 Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension Completed
Phase 3 Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine Completed
Phase 3 Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy Completed
Phase 3 Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension Completed
Phase 3 An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure Completed
Phase 3 Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension Completed
Phase 3 Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension Completed
Phase 3 Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension Completed
Phase 3 A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly Completed
Phase 3 Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension Completed
Phase 3 Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension Completed
Phase 3 Filtered Trial for Amlodipine Non-responder Completed
Phase 2 Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) Completed
Phase 2 Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension Completed
Phase 2 A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension Completed
Phase 2 Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome Completed
Phase 2 The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension Completed
Phase 2 L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients Completed
Phase 2 Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects Completed
Phase 2 Calcium Channel Blockade in Primary Aldosteronism Completed
Phase 1 Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet Completed
Phase 1 Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010) Completed

Showing the 50 most-cited and recently-updated of 60 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.